Hims & Hers Health ( (HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hims & Hers Health stock took a hit after legal troubles emerged, with Novo Nordisk terminating their partnership over allegations of illegal sales. Following this, Truist adjusted its price target downward, pointing to worries about the company’s revenue mix and growth prospects, even though GLP-1 revenue is expected to rise. The combination of these challenges and a mixed earnings report has left analysts feeling cautious.
More about Hims & Hers Health
YTD Price Performance: 78.97%
Average Trading Volume: 39,487,873
Technical Sentiment Signal: Buy
Current Market Cap: $10.4B
For further insights into HIMS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.